Apollo Endosurgery 주식 주식분석 | 주식가격 | 뉴스 | APEN | US03767D1081 | A2DJ26

날짜	Apollo Endosurgery 주식 가격
	10.00 undefined
	10.00 undefined

날짜	Apollo Endosurgery 매출	Apollo Endosurgery EBIT	Apollo Endosurgery 이익
2026e	131.47 백만 undefined	-27.64 백만 undefined	-42.34 백만 undefined
2025e	184.47 백만 undefined	-27.67 백만 undefined	-37.27 백만 undefined
2024e	111.2 백만 undefined	-26.05 백만 undefined	-34.92 백만 undefined
2023e	91.02 백만 undefined	-29.62 백만 undefined	-40.45 백만 undefined
2022	76.86 백만 undefined	-27.82 백만 undefined	-39.84 백만 undefined
2021	62.99 백만 undefined	-19.2 백만 undefined	-24.68 백만 undefined
2020	42.05 백만 undefined	-15.79 백만 undefined	-22.61 백만 undefined
2019	50.71 백만 undefined	-29.12 백만 undefined	-27.43 백만 undefined
2018	60.85 백만 undefined	-32.32 백만 undefined	-45.79 백만 undefined
2017	64.31 백만 undefined	-22.44 백만 undefined	-27.29 백만 undefined
2016	64.65 백만 undefined	-20.76 백만 undefined	-41.17 백만 undefined
2015	67.79 백만 undefined	-16.68 백만 undefined	-36.38 백만 undefined
2014	5.08 백만 undefined	-17.81 백만 undefined	-16.56 백만 undefined
2013	7.99 백만 undefined	-7.59 백만 undefined	-6.56 백만 undefined
2012	6.69 백만 undefined	-5.56 백만 undefined	-2.75 백만 undefined
2011	9.39 백만 undefined	-3.71 백만 undefined	-3.11 백만 undefined
2010	7.84 백만 undefined	-4.49 백만 undefined	-4.6 백만 undefined
2009	11.91 백만 undefined	1.8 백만 undefined	3.98 백만 undefined
2008	2.86 백만 undefined	-11.74 백만 undefined	-11.46 백만 undefined
2007	370,000 undefined	-15.48 백만 undefined	-15.09 백만 undefined

	매출	EBIT	이익
2007	370,000 USD	-15.48 백만 USD	-15.09 백만 USD
2008	2.86 백만 USD	-11.74 백만 USD	-11.46 백만 USD
2009	11.91 백만 USD	1.8 백만 USD	3.98 백만 USD
2010	7.84 백만 USD	-4.49 백만 USD	-4.6 백만 USD
2011	9.39 백만 USD	-3.71 백만 USD	-3.11 백만 USD
2012	6.69 백만 USD	-5.56 백만 USD	-2.75 백만 USD
2013	7.99 백만 USD	-7.59 백만 USD	-6.56 백만 USD
2014	5.08 백만 USD	-17.81 백만 USD	-16.56 백만 USD
2015	67.79 백만 USD	-16.68 백만 USD	-36.38 백만 USD
2016	64.65 백만 USD	-20.76 백만 USD	-41.17 백만 USD
2017	64.31 백만 USD	-22.44 백만 USD	-27.29 백만 USD
2018	60.85 백만 USD	-32.32 백만 USD	-45.79 백만 USD
2019	50.71 백만 USD	-29.12 백만 USD	-27.43 백만 USD
2020	42.05 백만 USD	-15.79 백만 USD	-22.61 백만 USD
2021	62.99 백만 USD	-19.2 백만 USD	-24.68 백만 USD
2022	76.86 백만 USD	-27.82 백만 USD	-39.84 백만 USD
2023e	91.02 백만 USD	-29.62 백만 USD	-40.45 백만 USD
2024e	111.2 백만 USD	-26.05 백만 USD	-34.92 백만 USD
2025e	184.47 백만 USD	-27.67 백만 USD	-37.27 백만 USD
2026e	131.47 백만 USD	-27.64 백만 USD	-42.34 백만 USD

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023e	2024e	2025e	2026e
0	2	11	7	9	6	7	5	67	64	64	60	50	42	62	76	91	111	184	131
-	-	450.00	-36.36	28.57	-33.33	16.67	-28.57	1,240.00	-4.48	-	-6.25	-16.67	-16.00	47.62	22.58	19.74	21.98	65.77	-28.80
-	2,100.00	381.82	600.00	466.67	700.00	600.00	840.00	70.15	60.94	60.94	55.00	50.00	52.38	54.84	55.26	46.15	37.84	22.83	32.06
0	0	0	0	0	0	0	0	47	39	39	33	25	22	34	42	0	0	0	0
-15	-11	3	-4	-3	-2	-6	-16	-36	-41	-27	-45	-27	-22	-24	-39	-40	-34	-37	-42
-	-26.67	-127.27	-233.33	-25.00	-33.33	200.00	166.67	125.00	13.89	-34.15	66.67	-40.00	-18.52	9.09	62.50	2.56	-15.00	8.82	13.51
0.07	0.09	0.11	0.1	0.12	0.14	0.17	0.21	0.24	0.39	13.57	19.79	21.54	22.76	30.24	40.65	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022

7.5	7.8	6.2	6.8	14.4	24.6	11.9	17.3	21.7	19.1	30.5	24	29.9	36.2	90.69	57
0	0.7	0.3	15.4	1.3	0.2	1.3	0.7	10.5	10.5	11.7	11.4	9.2	8.2	10.08	14.99
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	12.8	12.2	14.3	9.9	8.9	10.3	11.97	18.25
0.2	0.2	0.2	0.2	0.3	0.3	0.3	0.4	2.1	1.8	1	2.8	3	3.8	1.97	2.64
7.7	8.7	6.7	22.4	16	25.1	13.5	18.4	47.1	43.6	57.5	48.1	51	58.5	114.7	92.88
0.4	0.3	0.2	0.1	0.2	0.3	0.2	0.2	8	6.9	6.9	5.9	6.6	6.2	5.59	7.51
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.4	0.5	0.9	1.3	1.6	1.7	1.9	2.2	49	43.3	36.4	9.9	7.8	6	4.4	3.12
0	0	0	0	0	0	0	0	0.2	6.8	6.8	5.3	5.3	5.3	5.29	5.29
0	0	0	0	0.1	0.1	0.1	0.1	1	1.5	1.3	5.3	3.8	1.4	1.55	1.44
0.8	0.8	1.1	1.4	1.9	2.1	2.2	2.5	58.2	58.5	51.4	26.4	23.5	18.9	16.83	17.35
8.5	9.5	7.8	23.8	17.9	27.2	15.7	20.9	105.3	102.1	108.9	74.5	74.5	77.4	131.53	110.23

0	0.1	0.1	0.1	0	0	0	0	144.9	0	0	0	0	0	0.04	0.04
34.5	43.1	34.3	40	40.8	57.8	59.4	81.8	-25.2	190.7	225.1	249.1	250.6	276.6	356.52	364.87
-28.2	-39.6	-32.4	-37	-40.2	-42.9	-49.5	-66	-108.6	-149.7	-177	-222.8	-250.2	-272.8	-297.46	-337.29
0	0	0	0	0	0	0	0	0	1.5	1.8	2.5	1.6	2.9	2.14	4.97
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
6.3	3.6	2	3.1	0.6	14.9	9.9	15.8	11.1	42.5	49.9	28.8	2	6.7	61.24	32.59
1	1.1	0.3	0.5	2.2	1	2	2.9	4.7	5.1	18.3	15.3	9.9	3.7	4.58	7.42
0.6	0.9	0.9	2.3	1.8	2.2	1	1.2	6.4	6.4	7.5	9.2	6.8	7.4	9.9	12.4
0	3.4	0.7	6.7	6.1	5.4	0.5	0.2	10.2	8.7	0	0	1.6	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	34.4	0.6	0	19.71
1.6	5.4	1.9	9.5	10.1	8.6	3.5	4.3	21.3	20.2	25.8	24.5	52.7	11.7	14.49	39.54
0	0	0	0	0	0	0	0	69.8	39.4	33.3	21.2	18.6	56.6	52.99	33.96
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.7	0.5	4.1	11.4	7.2	3.6	2.2	0.9	2.9	0	0	0	1.1	2.4	2.82	4.14
0.7	0.5	4.1	11.4	7.2	3.6	2.2	0.9	72.7	39.4	33.3	21.2	19.7	59	55.81	38.1
2.3	5.9	6	20.9	17.3	12.2	5.7	5.2	94	59.6	59.1	45.7	72.4	70.7	70.29	77.64
8.6	9.5	8	24	17.9	27.1	15.6	21	105.1	102.1	109	74.5	74.4	77.4	131.53	110.23

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
-15	-11	3	-4	-3	-2	-6	-16	-27	-41	-27	-45	-27	-22	-24	-39
0	0	0	0	0	0	0	0	8	9	9	9	4	3	3	2
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1	3	-3	0	10	-3	-6	1	-3	0	1	1	0	-7	0	-6
2	1	-1	1	0	-2	0	0	6	18	2	11	-2	5	6	12
0	0	0	0	0	0	0	0	4	5	3	3	3	3	6	2
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-10	-6	-1	-3	8	-8	-13	-15	-16	-12	-13	-23	-25	-20	-14	-31
0	0	0	0	0	0	0	0	-6	-2	-2	-2	0	0	-1	-2
0	0	0	0	0	0	0	0	-6	-2	-2	7	1	1	1	-2
0	0	0	0	0	0	0	0	0	0	0	10	2	2	3	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	34	-11	-7	-12	33	2	-3	0
17	6	0	4	0	19	0	21	0	29	33	22	0	23	72	0
17	6	0	4	0	18	0	21	33	12	26	9	30	25	67	0
-	-	-	-	-	-	-	-	-1.00	-5.00	-	-	-2.00	-	-1.00	-
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
6	0	-1	0	7	10	-12	5	10	-2	11	-6	5	6	54	-33
-11.2	-6.31	-1.62	-4.06	7.57	-8.65	-13.54	-15.73	-22.79	-15.27	-15.46	-26	-26.6	-21.44	-15.91	-34.01
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Apollo Endosurgery 브루토마진	Apollo Endosurgery 이익 마진	Apollo Endosurgery EBIT-마진	Apollo Endosurgery 이익 마진
2026e	55.2 %	-21.02 %	-32.21 %
2025e	55.2 %	-15 %	-20.2 %
2024e	55.2 %	-23.43 %	-31.4 %
2023e	55.2 %	-32.54 %	-44.44 %
2022	55.2 %	-36.2 %	-51.84 %
2021	55.5 %	-30.48 %	-39.18 %
2020	52.89 %	-37.55 %	-53.77 %
2019	50.64 %	-57.42 %	-54.09 %
2018	54.54 %	-53.11 %	-75.25 %
2017	61.78 %	-34.89 %	-42.44 %
2016	60.94 %	-32.11 %	-63.68 %
2015	69.74 %	-24.61 %	-53.67 %
2014	55.2 %	-350.59 %	-325.98 %
2013	55.2 %	-94.99 %	-82.1 %
2012	55.2 %	-83.11 %	-41.11 %
2011	55.2 %	-39.51 %	-33.12 %
2010	55.2 %	-57.27 %	-58.67 %
2009	55.2 %	15.11 %	33.42 %
2008	55.2 %	-410.49 %	-400.7 %
2007	55.2 %	-4,183.78 %	-4,078.38 %

	브루토마진	EBIT-마진	이익 마진
2007	55.2 %	-4,183.78 %	-4,078.38 %
2008	55.2 %	-410.49 %	-400.7 %
2009	55.2 %	15.11 %	33.42 %
2010	55.2 %	-57.27 %	-58.67 %
2011	55.2 %	-39.51 %	-33.12 %
2012	55.2 %	-83.11 %	-41.11 %
2013	55.2 %	-94.99 %	-82.1 %
2014	55.2 %	-350.59 %	-325.98 %
2015	69.74 %	-24.61 %	-53.67 %
2016	60.94 %	-32.11 %	-63.68 %
2017	61.78 %	-34.89 %	-42.44 %
2018	54.54 %	-53.11 %	-75.25 %
2019	50.64 %	-57.42 %	-54.09 %
2020	52.89 %	-37.55 %	-53.77 %
2021	55.5 %	-30.48 %	-39.18 %
2022	55.2 %	-36.2 %	-51.84 %
2023e	55.2 %	-32.54 %	-44.44 %
2024e	55.2 %	-23.43 %	-31.4 %
2025e	55.2 %	-15 %	-20.2 %
2026e	55.2 %	-21.02 %	-32.21 %

날짜	Apollo Endosurgery 주당 매출	Apollo Endosurgery EBIT 당 주식	Apollo Endosurgery 주당 이익
2026e	2.76 undefined	0 undefined	-0.89 undefined
2025e	3.88 undefined	0 undefined	-0.78 undefined
2024e	2.34 undefined	0 undefined	-0.73 undefined
2023e	1.91 undefined	0 undefined	-0.85 undefined
2022	1.89 undefined	-0.68 undefined	-0.98 undefined
2021	2.08 undefined	-0.63 undefined	-0.82 undefined
2020	1.85 undefined	-0.69 undefined	-0.99 undefined
2019	2.35 undefined	-1.35 undefined	-1.27 undefined
2018	3.07 undefined	-1.63 undefined	-2.31 undefined
2017	4.74 undefined	-1.65 undefined	-2.01 undefined
2016	165.77 undefined	-53.23 undefined	-105.56 undefined
2015	282.46 undefined	-69.5 undefined	-151.58 undefined
2014	24.19 undefined	-84.81 undefined	-78.86 undefined
2013	47 undefined	-44.65 undefined	-38.59 undefined
2012	47.79 undefined	-39.71 undefined	-19.64 undefined
2011	78.25 undefined	-30.92 undefined	-25.92 undefined
2010	78.4 undefined	-44.9 undefined	-46 undefined
2009	108.27 undefined	16.36 undefined	36.18 undefined
2008	31.78 undefined	-130.44 undefined	-127.33 undefined
2007	5.29 undefined	-221.14 undefined	-215.57 undefined

	주당 매출	EBIT 당 주식	주당 이익
2007	5.29 USD	-221.14 USD	-215.57 USD
2008	31.78 USD	-130.44 USD	-127.33 USD
2009	108.27 USD	16.36 USD	36.18 USD
2010	78.4 USD	-44.9 USD	-46 USD
2011	78.25 USD	-30.92 USD	-25.92 USD
2012	47.79 USD	-39.71 USD	-19.64 USD
2013	47 USD	-44.65 USD	-38.59 USD
2014	24.19 USD	-84.81 USD	-78.86 USD
2015	282.46 USD	-69.5 USD	-151.58 USD
2016	165.77 USD	-53.23 USD	-105.56 USD
2017	4.74 USD	-1.65 USD	-2.01 USD
2018	3.07 USD	-1.63 USD	-2.31 USD
2019	2.35 USD	-1.35 USD	-1.27 USD
2020	1.85 USD	-0.69 USD	-0.99 USD
2021	2.08 USD	-0.63 USD	-0.82 USD
2022	1.89 USD	-0.68 USD	-0.98 USD
2023e	1.91 USD	0 USD	-0.85 USD
2024e	2.34 USD	0 USD	-0.73 USD
2025e	3.88 USD	0 USD	-0.78 USD
2026e	2.76 USD	0 USD	-0.89 USD

Segmente	2022	2021	2020	2019	2018	2017	2016
ESS	53.85 백만 USD	39.97 백만 USD	25.73 백만 USD	28.31 백만 USD	-	-	-
IGB	22.26 백만 USD	22.1 백만 USD	14.78 백만 USD	16.84 백만 USD	-	-	-
Endo-Bariatric	-	-	-	45.15 백만 USD	-	-	-
Total Endoscopy	-	-	40.51 백만 USD	-	-	-	-
Other	748,000 USD	927,000 USD	1.54 백만 USD	1.85 백만 USD	-	-	-
Surgical	-	-	-	3.71 백만 USD	-	-	-

	ESS	IGB	Endo-Bariatric	Total Endoscopy	Other	Surgical
2016	0 USD	0 USD	0 USD	0 USD	0 USD	0 USD
2017	0 USD	0 USD	0 USD	0 USD	0 USD	0 USD
2018	0 USD	0 USD	0 USD	0 USD	0 USD	0 USD
2019	28.31 백만 USD	16.84 백만 USD	45.15 백만 USD	0 USD	1.85 백만 USD	3.71 백만 USD
2020	25.73 백만 USD	14.78 백만 USD	0 USD	40.51 백만 USD	1.54 백만 USD	0 USD
2021	39.97 백만 USD	22.1 백만 USD	0 USD	0 USD	927,000 USD	0 USD
2022	53.85 백만 USD	22.26 백만 USD	0 USD	0 USD	748,000 USD	0 USD

Segmente	2022	2021	2020	2019	2018	2017	2016
Endo-Bariatric	-	-	-	-	41.12 백만 USD	35.92 백만 USD	-
Surgical	-	-	-	-	18.71 백만 USD	27.59 백만 USD	-
ESS	-	-	-	-	23.38 백만 USD	-	-
IGB	-	-	-	-	17.74 백만 USD	-	-
Other	-	-	-	-	1.03 백만 USD	794,000 USD	-

	Endo-Bariatric	Surgical	ESS	IGB	Other
2016	0 USD	0 USD	0 USD	0 USD	0 USD
2017	35.92 백만 USD	27.59 백만 USD	0 USD	0 USD	794,000 USD
2018	41.12 백만 USD	18.71 백만 USD	23.38 백만 USD	17.74 백만 USD	1.03 백만 USD
2019	0 USD	0 USD	0 USD	0 USD	0 USD
2020	0 USD	0 USD	0 USD	0 USD	0 USD
2021	0 USD	0 USD	0 USD	0 USD	0 USD
2022	0 USD	0 USD	0 USD	0 USD	0 USD

Segmente	2022	2021	2020	2019	2018	2017	2016
Endo-Bariatric	-	-	-	-	-	-	16.38 백만 USD
Surgical	-	-	-	-	-	-	10.71 백만 USD
Other	-	-	-	-	-	-	24,000 USD

	Endo-Bariatric	Surgical	Other
2016	16.38 백만 USD	10.71 백만 USD	24,000 USD
2017	0 USD	0 USD	0 USD
2018	0 USD	0 USD	0 USD
2019	0 USD	0 USD	0 USD
2020	0 USD	0 USD	0 USD
2021	0 USD	0 USD	0 USD
2022	0 USD	0 USD	0 USD

날짜	Other countries	Other Countries	OUS	Outside of US	U.S	United States
2022	-	-	32.9 백만 USD	-	43.96 백만 USD	-
2021	-	28.99 백만 USD	-	-	34 백만 USD	-
2020	-	19.78 백만 USD	-	-	22.27 백만 USD	-
2019	-	-	-	28.79 백만 USD	21.92 백만 USD	-
2018	-	-	-	32.65 백만 USD	28.21 백만 USD	-
2017	31.86 백만 USD	-	-	-	32.45 백만 USD	-
2016	27.11 백만 USD	-	-	-	-	37.76 백만 USD

	Other countries	Other Countries	OUS	Outside of US	U.S	United States
2016	27.11 백만 USD	0 USD	0 USD	0 USD	0 USD	37.76 백만 USD
2017	31.86 백만 USD	0 USD	0 USD	0 USD	32.45 백만 USD	0 USD
2018	0 USD	0 USD	0 USD	32.65 백만 USD	28.21 백만 USD	0 USD
2019	0 USD	0 USD	0 USD	28.79 백만 USD	21.92 백만 USD	0 USD
2020	0 USD	19.78 백만 USD	0 USD	0 USD	22.27 백만 USD	0 USD
2021	0 USD	28.99 백만 USD	0 USD	0 USD	34 백만 USD	0 USD
2022	0 USD	0 USD	32.9 백만 USD	0 USD	43.96 백만 USD	0 USD

	주식 수량
2007	70,000 Aktien
2008	90,000 Aktien
2009	110,000 Aktien
2010	100,000 Aktien
2011	120,000 Aktien
2012	140,000 Aktien
2013	170,000 Aktien
2014	210,000 Aktien
2015	240,000 Aktien
2016	390,000 Aktien
2017	13.57 백만 Aktien
2018	19.79 백만 Aktien
2019	21.54 백만 Aktien
2020	22.76 백만 Aktien
2021	30.24 백만 Aktien
2022	40.65 백만 Aktien
2023e	40.65 백만 Aktien
2024e	40.65 백만 Aktien
2025e	40.65 백만 Aktien
2026e	40.65 백만 Aktien

EPS-예상치	EPS-실제	보고 분기
-0.21	-0.23 (-7.89 %)	2022 Q4
-0.24	-0.28 (-18.34 %)	2022 Q3
-0.23	-0.26 (-13.29 %)	2022 Q2
-0.2	-0.21 (-4.69 %)	2022 Q1
-0.2	-0.27 (-38.11 %)	2021 Q4
-0.29	-0.23 (19.47 %)	2021 Q3
-0.2	-0.22 (-9.67 %)	2021 Q2
-0.22	-0.17 (24.24 %)	2021 Q1
-0.26	-0.14 (46.17 %)	2020 Q4
-0.21	-0.11 (48.65 %)	2020 Q3
-0.34	-0.3 (10.87 %)	2020 Q2
-0.5	-0.49 (1.96 %)	2020 Q1
-0.39	-0.34 (12.28 %)	2019 Q4
-0.43	-0.4 (6.63 %)	2019 Q3
-0.39	-0.4 (-3.2 %)	2019 Q2
-0.37	-0.38 (-2.07 %)	2019 Q1
-0.37	-0.48 (-28.34 %)	2018 Q4
-0.36	-0.45 (-25.14 %)	2018 Q3
-0.45	-0.53 (-17.41 %)	2018 Q2
-0.41	-0.47 (-15.2 %)	2018 Q1
-0.35	-0.42 (-21.11 %)	2017 Q4
-0.41	-0.32 (22.22 %)	2017 Q3
-0.24	-0.64 (-161.44 %)	2017 Q2
-26.7	-26.18 (1.96 %)	2014 Q4
-25.92	-15.4 (40.58 %)	2014 Q3
-11.52	-17.71 (-53.74 %)	2014 Q2
-9.03	-17.71 (-96.08 %)	2014 Q1
-7.85	-8.47 (-7.84 %)	2013 Q4
-14.4	-14.63 (-1.61 %)	2013 Q3
-20.42	-10.78 (47.21 %)	2013 Q2
-10.21	-8.47 (17.04 %)	2013 Q1
-11.39	-12.32 (-8.18 %)	2012 Q4
-7.07	-7.7 (-8.93 %)	2012 Q3
-11	0 (100 %)	2012 Q2
-11	5.39 (149.02 %)	2012 Q1
-16.49	-32.34 (-96.08 %)	2011 Q4
0	-10.78 (0 %)	2010 Q2
0	5.39 (0 %)	2010 Q1
0	0 (0 %)	2009 Q4
-5.5	70.07 (1,374.51 %)	2009 Q3
-49.48	-53.9 (-8.93 %)	2007 Q3

%-지분	이름	주식	변경
13.00464 %	CPMG, Inc.	6,183,603	2,219,962
9.98999 %	Nantahala Capital Management, LLC	4,750,161	693,534
7.83732 %	Stonepine Capital Management, LLC	3,726,584	0
5.01913 %	Citi Investment Research (US)	2,386,557	376,119
3.68040 %	Deerfield Management Company, L.P.	1,750,000	0
3.46051 %	Archon Capital Management LLC	1,645,443	-196,641
3.11922 %	Lytton (Laurence W)	1,483,162	1,183,979
3.08600 %	The Vanguard Group, Inc.	1,467,367	105,589
2.25945 %	J.P. Morgan Securities LLC	1,074,350	1,074,350
1.65473 %	AWM Investment Company, Inc.	786,809	-43,288
1.60423 %	Woodline Partners LP	762,800	762,800
1.51090 %	Boone Capital Management LLC	718,419	718,419
1.50894 %	Gagnon Securities LLC	717,490	-985,685
1.31443 %	Berry Street Capital Management LLP	625,000	625,000
1.10859 %	Parian Global Management LP	527,126	-205,840
1.07916 %	Gabelli Funds, LLC	513,131	510,631
1.06318 %	BlackRock Institutional Trust Company, N.A.	505,532	-57,854
0.99826 %	Vivaldi Asset Management, LLC	474,664	474,664
0.94562 %	Water Island Capital, LLC	449,636	90,636
0.92517 %	Millennium Management LLC	439,913	388,982
0.87319 %	Magnetar Capital Partners LP	415,194	415,194
0.78446 %	Gilder Gagnon Howe & Co. LLC	373,005	-88,582
0.78304 %	Geode Capital Management, L.L.C.	372,329	28,878
0.71337 %	Morgan Stanley & Co. LLC	339,200	339,200
0.69768 %	IndexIQ Advisors LLC	331,741	331,741
0.64775 %	Federated Hermes Global Investment Management Corp.	308,000	308,000
0.60157 %	Qube Research & Technologies Ltd	286,040	286,040
0.55989 %	Newton (K Todd)	266,223	125,817
0.54115 %	Bardin Hill Investment Partners LP	257,312	257,312
0.50209 %	AIGH Capital Management, LLC.	238,740	-143,261
0.46976 %	McKhann (Charles S.)	223,365	63,943
0.44081 %	Renaissance Technologies LLC	209,600	114,300
0.41360 %	TIG Advisors, L.L.C.	196,665	196,665
0.36846 %	Bridgeway Capital Management, LLC	175,200	0
0.35752 %	Apis Capital Advisors LLC	170,000	30,000
0.34846 %	GWM Asset Management, Ltd.	165,691	165,691
0.34269 %	Glazer Capital, LLC	162,947	162,947
0.34180 %	Susquehanna International Group, LLP	162,525	162,525
0.33957 %	Russell Investments Trust Company	161,463	-77,370
0.32335 %	Cigogne Management S.A.	153,750	153,750
0.31231 %	Northern Trust Investments, Inc.	148,499	3,585
0.29233 %	BCK Capital Management LP	139,000	139,000
0.28670 %	Boston Partners	136,323	-32,210
0.27340 %	New Jersey Division of Investment	130,000	0
0.24809 %	State Street Global Advisors (US)	117,966	28,600
0.23902 %	Cavanaugh (Stefanie L CPA)	113,653	70,993
0.23049 %	Anderson (Rick D)	109,596	14,224
0.21820 %	Black (Jeffrey G)	103,750	-38,900
0.16950 %	HRT Financial LP	80,598	80,598
0.16720 %	Goldman Sachs & Company, Inc.	79,502	-746,980
0.16340 %	Worth Venture Partners, LLC	77,696	-48,839
0.14665 %	Goldman Sachs Bank AG	69,731	0
0.12881 %	Dimensional Fund Advisors, L.P.	61,247	-5,142
0.10597 %	Molesphini (John J)	50,386	23,106
0.10561 %	CSS, LLC	50,215	50,215
0.10515 %	Neuberger Berman, LLC	50,000	0
0.10515 %	Harvest Management, LLC	50,000	50,000
0.10299 %	Trexquant Investment LP	48,973	48,973
0.10114 %	Northern Trust Global Investments	48,090	0
0.09201 %	Maven Investment Partners US Ltd.	43,751	43,751
0.08740 %	Jane Street Capital, L.L.C.	41,559	41,559
0.08615 %	BofA Global Research (US)	40,965	1,758
0.08187 %	Newton Investment Management North America, LLC	38,930	0
0.07849 %	Crystalline Management, Inc.	37,319	37,319
0.07488 %	O'Keefe (Sharon L)	35,604	35,604
0.07483 %	Jump Financial, LLC	35,582	24,382
0.07430 %	UBS Financial Services, Inc.	35,328	31,773
0.06833 %	Trium Capital LLP	32,488	32,488
0.06562 %	University of Texas Investment Management Company	31,202	0
0.06279 %	Barr (John R)	29,858	-10,336
0.05684 %	McClellan (William D Jr)	27,025	-10,336
0.05678 %	Thompson, Davis & Co., Inc. (Asset Management)	27,000	-47,078
0.05664 %	Schonfeld Strategic Advisors LLC	26,931	26,931
0.05074 %	Quantbot Technologies, LP	24,125	24,125
0.04584 %	Shimer (Julie Ann)	21,797	-10,336
0.04127 %	Cubist Systematic Strategies, LLC	19,623	19,623
0.03735 %	Barclays Capital Inc.	17,762	16,604
0.03710 %	Bankes (Jeannette)	17,641	14,224
0.03617 %	Charles Schwab Investment Management, Inc.	17,198	0
0.03578 %	BNY Mellon Asset Management	17,011	7,594
0.03379 %	Lighthouse Partners	16,065	16,065
0.02923 %	Highland Capital Management Fund Advisors, L.P.	13,900	13,900
0.02734 %	Verition Fund Management LLC	13,000	13,000
0.02672 %	Balyasny Asset Management LP	12,706	12,706
0.02662 %	Squarepoint Capital LLP	12,658	12,658
0.02549 %	Mirabella Financial Services LLP	12,120	12,120
0.02345 %	Morris Financial Concepts, INC	11,149	11,149
0.02191 %	Citadel Advisors LLC	10,417	-55,610
0.01414 %	Wolverine Asset Management, LLC	6,724	6,724
0.01301 %	BlackRock Investment Management, LLC	6,186	554
0.01301 %	Lord, Abbett & Co. LLC	6,186	0
0.01199 %	Lazard Asset Management, L.L.C.	5,701	-5,203
0.00818 %	Pacitti (David)	3,888	-10,336
0.00735 %	Tower Research Capital LLC	3,495	3,231
0.00486 %	Invesco Capital Management LLC	2,312	0
0.00411 %	Morgan Stanley Smith Barney LLC	1,952	0
0.00314 %	Morgan Stanley & Co. International Plc	1,495	1,495
0.00273 %	Cutler Group, LP	1,300	1,300
0.00215 %	BlackRock Financial Management, Inc.	1,023	-2,271
0.00212 %	Russell Investments Limited	1,006	-937

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
Olympus	공급업체고객	0,74	0,69	-0,18	0,57	0,21	0,72

What values and corporate philosophy does Apollo Endosurgery represent?

Apollo Endosurgery Inc represents a strong commitment to bringing innovative and minimally invasive medical devices and solutions to the healthcare industry. With a focus on improving patient outcomes and enhancing quality of life, the company excels in providing effective solutions for weight loss and gastrointestinal disorders. Apollo Endosurgery Inc is known for its dedication to advancing medical technology and facilitating collaboration with healthcare professionals to address the evolving needs of patients. By combining clinical expertise and cutting-edge research, the company aims to revolutionize the field of endoscopic surgery and deliver superior value to patients, healthcare providers, and stakeholders.

In which countries and regions is Apollo Endosurgery primarily present?

Apollo Endosurgery Inc is primarily present in the United States.

What significant milestones has the company Apollo Endosurgery achieved?

Apollo Endosurgery Inc, a renowned medical technology company, has achieved several significant milestones over the years. One noteworthy accomplishment is the FDA approval of their flagship product, the Orbera Intragastric Balloon System. This innovative weight loss solution has helped numerous individuals achieve their weight loss goals. Additionally, Apollo Endosurgery's OverStitch Endoscopic Suturing System received FDA clearance, enabling minimally invasive endoscopic suturing procedures. These milestones demonstrate the company's dedication to enhancing patient care and advancing the field of endoscopy. Apollo Endosurgery Inc continues to develop groundbreaking medical technologies, solidifying its position as a leader in the industry.

What is the history and background of the company Apollo Endosurgery?

Apollo Endosurgery Inc is a renowned medical technology company focused on the development and commercialization of innovative gastrointestinal therapeutic solutions. Founded in 2006, the company has successfully established itself as a leader in the field of minimally invasive surgical and endoscopic technologies. Apollo Endosurgery is committed to providing effective and safe solutions for obesity, gastrointestinal disorders, and other related conditions. With a dedicated team of experts and a strong emphasis on research and development, the company continues to introduce cutting-edge products that positively impact patient outcomes. Apollo Endosurgery Inc has emerged as a trusted name in the medical industry, driving advancements in endoscopic procedures and revolutionizing patient care.

Who are the main competitors of Apollo Endosurgery in the market?

The main competitors of Apollo Endosurgery Inc in the market include companies such as Medtronic PLC, Johnson & Johnson, Boston Scientific Corporation, and Olympus Corporation.

In which industries is Apollo Endosurgery primarily active?

Apollo Endosurgery Inc is primarily active in the medical device industry.

What is the business model of Apollo Endosurgery?

Apollo Endosurgery Inc. operates in the medical device industry, specializing in the development and commercialization of therapeutic medical devices. The company focuses on minimally invasive surgical solutions for the treatment of obesity, gastrointestinal disorders, and other medical conditions. Apollo Endosurgery Inc. offers a portfolio of cost-effective and innovative product offerings, including the OverStitch™ Endoscopic Suturing System and the ORBERA® Intragastric Balloon System. By providing advanced medical technologies, Apollo Endosurgery Inc. aims to improve patient outcomes, enhance physician productivity, and ultimately revolutionize the field of endoscopy.

Apollo Endosurgery 2024의 P/E 비율은 얼마입니까?

Apollo Endosurgery의 P/E 비율은 -11.64입니다.

Apollo Endosurgery 2024의 KUV는 얼마입니까?

Apollo Endosurgery의 P/S 비율은 3.66입니다.

Apollo Endosurgery의 AlleAktien 품질 점수는 얼마인가요?

Apollo Endosurgery에 대한 AlleAktien 품질 점수는 6/10입니다.

Apollo Endosurgery 2024의 매출은 얼마인가요?

예상되는 Apollo Endosurgery 매출은 111.2 백만 USD입니다.

Apollo Endosurgery 2024의 이익은 얼마인가요?

예상되는 Apollo Endosurgery 이익은 -34.92 백만 USD입니다.

Apollo Endosurgery은 무엇을 하나요?

Apollo Endosurgery Inc is a leading company that develops and manufactures medical devices and solutions for endoscopic surgery to treat obesity, GERD, and other gastrointestinal diseases.

Apollo Endosurgery 배당금은 얼마입니까?

Apollo Endosurgery은(는) 연간 번의 배당을 통해 0 USD의 배당금을 지급합니다.

Apollo Endosurgery이 얼마나 자주 배당을 지급하나요?

Apollo Endosurgery의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Apollo Endosurgery ISIN이 무엇입니까?

Apollo Endosurgery의 ISIN은 US03767D1081입니다.

Apollo Endosurgery WKN은 무엇인가요?

Apollo Endosurgery의 WKN은 A2DJ26입니다.

Apollo Endosurgery 티커는 무엇인가요?

Apollo Endosurgery의 티커는 APEN입니다.

Apollo Endosurgery이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Apollo Endosurgery은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Apollo Endosurgery은(는) 0 USD의 배당금을 지급할 것으로 예상됩니다.

Apollo Endosurgery의 배당 수익률은 얼마입니까?

Apollo Endosurgery의 현재 배당 수익률은 입니다.

Apollo Endosurgery의 배당금은 언제 지급되나요?

Apollo Endosurgery은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Apollo Endosurgery의 배당금은 얼마나 안전한가요?

Apollo Endosurgery은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

Apollo Endosurgery의 배당금은 얼마입니까?

향후 12개월 동안 0 USD의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

Apollo Endosurgery이(가) 속해 있는 섹터는 어디인가요?

Apollo Endosurgery은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Apollo Endosurgery kaufen, um die vorherige Dividende zu erhalten?

Apollo Endosurgery의 마지막 배당금을 0 USD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Apollo Endosurgery의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Apollo Endosurgery의 2023년도 배당금은 얼마였습니까?

2023년에 Apollo Endosurgery는 0 USD를 배당금으로 지급했습니다.

Apollo Endosurgery는 어떤 화폐로 배당금을 지급하나요?

Apollo Endosurgery의 배당금은 USD에 지급됩니다.

증권거래소	Apollo Endosurgery 티커
프랑크푸르트	HQ8F.F
NASDAQ	APEN

Apollo Endosurgery 티커	Apollo Endosurgery FIGI
HQ8F:GF	BBG000RGB519
HQ8F:GS	BBG000RGB5R1
HQ8F:GB	BBG000RGB6K6
APEN1EUR:EO	BBG00FPBMXC4
APEN1EUR:XH	BBG00FPBMXG0
APEN1EUR:XF	BBG00FPBMXJ7
APEN1EUR:XE	BBG00FPBMXL4
APEN1EUR:XJ	BBG00FPBMXM3
APEN1EUR:XL	BBG00FPBMXN2
APEN1EUR:XG	BBG00FPBMXP0
APEN1EUR:XO	BBG00FPBMXQ9
APEN1EUR:XS	BBG00FPBMXV3
APEN1EUR:XA	BBG00FPBMXW2
APEN1EUR:E1	BBG00FPBMXX1
APEN1EUR:XT	BBG00FPBMXY0
APEN1EUR:XW	BBG00FPBMXZ9
APEN1EUR:XU	BBG00FPBMY05
APEN1EUR:XV	BBG00FPBMY14
APEN1EUR:EU	BBG00FPBMY32
APEN1EUR:XX	BBG00JN8KS01
APEN1USD:XS	BBG00X5VCTC3
APEN1USD:X2	BBG00X5VCTD2
APEN1USD:XH	BBG00X5VCTG9
APEN1USD:XF	BBG00X5VCTJ6
APEN1USD:XE	BBG00X5VCTL3
APEN1USD:XJ	BBG00X5VCTM2
APEN1USD:XL	BBG00X5VCTN1
APEN1USD:XG	BBG00X5VCTP9
APEN1USD:XO	BBG00X5VCTQ8
APEN1USD:XA	BBG00X5VCTV2
APEN1USD:E1	BBG00X5VCTW1
APEN1USD:XT	BBG00X5VCTX0
APEN1USD:XW	BBG00X5VCTY9
APEN1USD:XU	BBG00X5VCTZ8
APEN1USD:XV	BBG00X5VCV10
APEN1USD:XM	BBG00X5VCV29
APEN1USD:XQ	BBG00X5VCV38
APEN1USD:XX	BBG00X5VCV47
APEN1USD:XZ	BBG00X5VCV56
APEN1USD:X1	BBG00X5VCV74
APEN1USD:EU	BBG00X5VCV92
APEN1GBP:XS	BBG00Z1J6CX0
APEN1GBP:X2	BBG00Z1J6CY9
APEN1GBP:XH	BBG00Z1J6D04
APEN1GBP:XF	BBG00Z1J6D22
APEN1GBP:XE	BBG00Z1J6D40
APEN1GBP:XJ	BBG00Z1J6D59
APEN1GBP:XL	BBG00Z1J6D68
APEN1GBP:XG	BBG00Z1J6D77
APEN1GBP:XO	BBG00Z1J6D86
APEN1GBP:XA	BBG00Z1J6DD0
APEN1GBP:E1	BBG00Z1J6DF8
APEN1GBP:XT	BBG00Z1J6DG7
APEN1GBP:XW	BBG00Z1J6DH6
APEN1GBP:XU	BBG00Z1J6DJ4
APEN1GBP:XV	BBG00Z1J6DL1
APEN1GBP:XM	BBG00Z1J6DM0
APEN1GBP:XQ	BBG00Z1J6DN9
APEN1GBP:XX	BBG00Z1J6DP7
APEN1GBP:XZ	BBG00Z1J6DQ6
APEN1GBP:X1	BBG00Z1J6DS4
APEN1GBP:EU	BBG00Z1J6DV0

한 눈에 저평가된 주식을 인식하세요

가격

가격

티커APEN

ISINUS03767D1081

WKNA2DJ26

Apollo Endosurgery 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

Apollo Endosurgery 주가 이력

Apollo Endosurgery 주식 매출, EBIT, 이익 US03767D1081 · A2DJ26

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Apollo Endosurgery 매출, 이익 및 EBIT 역사

Apollo Endosurgery 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Apollo Endosurgery 주식 마진 US03767D1081 · A2DJ26

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Apollo Endosurgery 마진 역사

Apollo Endosurgery 주식 매출, EBIT, 주당 순이익 US03767D1081 · A2DJ26

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Apollo Endosurgery 매출, 이익 및 EBIT 주당 역사

Apollo Endosurgery 주식 및 주식 분석

Apollo Endosurgery 매출 세분화 US03767D1081 · A2DJ26

세그먼트별 매출

세그먼트별 매출 개요

해석 및 사용

투자 전략

Apollo Endosurgery 매출 세분화

세그먼트별 매출

세그먼트별 매출 개요

해석 및 사용

투자 전략

Apollo Endosurgery 매출 세분화

세그먼트별 매출

세그먼트별 매출 개요

해석 및 사용

투자 전략

Apollo Endosurgery 매출 세분화

Apollo Endosurgery 지역별 매출 US03767D1081 · A2DJ26

세그먼트별 매출

지역별 매출 개요

해석 및 사용법

투자 전략

Apollo Endosurgery 매출 세분화

한눈에 과소평가된 주식을 인식하세요.

Apollo Endosurgery Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

티커
APEN

ISIN
US03767D1081

WKN
A2DJ26